Auddia Inc. Announces 2020 Financial Results and Progress Update
Full Product Rollouts in 2021
BOULDER, CO / ACCESSWIRE / April 1, 2021 / Auddia Inc. (NASDAQ:AUUD)(NASDAQ:AUUDW) ( Auddia or the Company ), developer of a proprietary AI platform for audio and innovative technologies for podcasts that is reinventing how consumers engage with audio, today announced financial results for the year ended December 31, 2020. A copy of the Company s Annual Report on Form 10-K can be found here: https://auddia.com/investor-page/
Jeff Thramann, the founder and executive chairman of Auddia, said, 2020 was a year of strong progress culminating in our initial public offering in February. With our large market opportunity, proprietary technology and differentiated product offerings, we believe we are well positioned to capitalize on the strong consumer interest we identified in surveys from the 133 million subscription audio and 270 million monthly radio listeners in the U.S. who expressed a s
Elys Game Technology to Participate at M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Auddia to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
(2)
Berwyn, Pennsylvania (Newsfile Corp. - March 17, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer s disease (AD), Parkinson s disease (PD) and other neurodegenerative diseases, today announced CEO Dr. Maria L. Maccecchini is presenting at Inaugural Emerging Growth Virtual Conference, presented by M Vest LLC and Maxim Group LLC. The online conference takes place March 17 and 18 from 9:00 a.m. to 5:00 p.m. EST.
To learn how to attend, visit HERE.
This presentation was pre-recorded prior to the Company s publication of results from its first interim analysis of its Phase 2a trial in AD and PD, which showed improvement in speed and coordination scores in PD patients following 25 days of treatment with ANVS401, the Company s lead drug candidate, with no serious adverse effects. Read full release for more details.
Avicannaâ or the â
Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce that Avicannaâs Chief Executive Officer, Aras Azadian has been invited to present at
Inaugural Emerging Growth Virtual Conference, presented by M Vest LLC and Maxim Group LLC. The conference will take place on March 17 and 18 from 9:00 am-5:00 pm EST featuring roundtable discussions with C-suite executives moderated by Maxim Research Analysts, fireside chats with live Q&A, and presentations from hundreds of issuers both domestically and internationally.
During this virtual conference, Avicanna will present along with other important voices in the cannabis industry. You will also hear from healthcare leaders treating a broad range of indications; cannabis entrepreneurs exploring the changing landscape; tech innovators changing how we work and pl